{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:09:49Z","timestamp":1780409389244,"version":"3.54.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12012-025-10087-3","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T12:12:50Z","timestamp":1768219970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Corticosteroid Use and Atrial Fibrillation: Exploring Underlying Mechanisms, FAERS Disproportionality Analysis, and a Meta-Analysis of Clinical Studies"],"prefix":"10.1007","volume":"26","author":[{"given":"Harri","family":"Hardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agian Jeffilano","family":"Barinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananda Pipphali","family":"Vidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Elliora","family":"Utama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liganda Endo","family":"Mahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"2","key":"10087_CR1","first-page":"203","volume":"14","author":"W Ericson-Neilsen","year":"2014","unstructured":"Ericson-Neilsen, W., & Kaye, A. D. (2014). Steroids: Pharmacology, complications, and practice delivery issues. Ochsner Journal, 14(2), 203\u2013207.","journal-title":"Ochsner Journal"},{"issue":"2","key":"10087_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/acr.21796","volume":"65","author":"RA Overman","year":"2013","unstructured":"Overman, R. A., Yeh, J., & Deal, C. L. (2013). Prevalence of oral glucocorticoid usage in the united states: A general population perspective. Arthritis Care Res (Hoboken), 65(2), 294\u2013298. https:\/\/doi.org\/10.1002\/acr.21796","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10087_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015237","volume":"7","author":"K Laugesen","year":"2017","unstructured":"Laugesen, K., J\u00f8rgensen, J. O. L., S\u00f8rensen, H. T., & Petersen, I. (2017). Systemic glucocorticoid use in Denmark: A population-based prevalence study. BMJ Open, 7(5), Article e015237. https:\/\/doi.org\/10.1136\/bmjopen-2016-015237","journal-title":"BMJ Open"},{"key":"10087_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000905","author":"JE Tisdale","year":"2020","unstructured":"Tisdale, J. E., Chung, M. K., Campbell, K. B., et al. (2020). Drug-induced arrhythmias: A scientific statement from the American heart association. Circulation. https:\/\/doi.org\/10.1161\/CIR.0000000000000905","journal-title":"Circulation"},{"issue":"11","key":"10087_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025130","volume":"100","author":"L Liu","year":"2021","unstructured":"Liu, L., Jing, F. Y., Wang, X. W., et al. (2021). Effects of corticosteroids on new-onset atrial fibrillation after cardiac surgery. Medicine, 100(11), Article e25130. https:\/\/doi.org\/10.1097\/MD.0000000000025130","journal-title":"Medicine"},{"issue":"1","key":"10087_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-022-03001-0","volume":"23","author":"Z Zhou","year":"2023","unstructured":"Zhou, Z., Long, Y., He, X., & Li, Y. (2023). Effects of different doses of glucocorticoids on postoperative atrial fibrillation: A meta-analysis. BMC Cardiovascular Disorders, 23(1), Article 16. https:\/\/doi.org\/10.1186\/s12872-022-03001-0","journal-title":"BMC Cardiovascular Disorders"},{"key":"10087_CR7","unstructured":"U.S. Food and Drug Administration. FDA Adverse Event Reporting System (FAERS) (2023). Accessed 9 Mar 2025. https:\/\/www.fda.gov\/drugs\/questions-and-answers-fdas-adverse-event-reporting-system-faers\/fda-adverse-event-reporting-system-faers-public-dashboard"},{"key":"10087_CR8","unstructured":"U.S. Food and Drug Administration. Data Mining at FDA -- White Paper. August 20, (2018). Accessed 11 Mar 2025. https:\/\/www.fda.gov\/science-research\/data-mining\/data-mining-fda-white-paper"},{"key":"10087_CR9","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"29","author":"MJ Page","year":"2021","unstructured":"Page, M. J., McKenzie, J. E., Bossuyt, P. M., et al. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ Published Online March, 29, n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ Published Online March"},{"issue":"5","key":"10087_CR10","doi-asserted-by":"publisher","first-page":"460","DOI":"10.4103\/0019-5154.139874","volume":"59","author":"S Dhar","year":"2014","unstructured":"Dhar, S., Seth, J., & Parikh, D. (2014). Systemic side-effects of topical corticosteroids. Indian Journal of Dermatology, 59(5), 460. https:\/\/doi.org\/10.4103\/0019-5154.139874","journal-title":"Indian Journal of Dermatology"},{"issue":"9","key":"10087_CR11","doi-asserted-by":"publisher","first-page":"e0138237","DOI":"10.1371\/journal.pone.0138237","volume":"10","author":"NR Haddaway","year":"2015","unstructured":"Haddaway, N. R., Collins, A. M., Coughlin, D., & Kirk, S. (2015). The role of Google scholar in evidence reviews and its applicability to grey literature searching. PLoS One, 10(9), e0138237. https:\/\/doi.org\/10.1371\/journal.pone.0138237","journal-title":"PLoS One"},{"key":"10087_CR12","doi-asserted-by":"publisher","DOI":"10.3310\/hta7270","author":"J Deeks","year":"2003","unstructured":"Deeks, J., Dinnes, J., D\u2019Amico, R., et al. (2003). Evaluating non-randomised intervention studies. Health Technol Assess (Rockv). https:\/\/doi.org\/10.3310\/hta7270","journal-title":"Health Technol Assess (Rockv)"},{"key":"10087_CR13","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne, J. A. C., Savovi\u0107, J., Page, M. J., et al. (2019). RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ Published Online August, 28, l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ Published Online August"},{"issue":"2","key":"10087_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1210\/jcem-54-2-332","volume":"54","author":"NC Lan","year":"1982","unstructured":"Lan, N. C., Graham, B., Bartter, F. C., & Baxter, J. D. (1982). Binding of steroids to mineralocorticoid receptors: Implications for in vivo occupancy by glucocorticoids*. Journal of Clinical Endocrinology and Metabolism, 54(2), 332\u2013342. https:\/\/doi.org\/10.1210\/jcem-54-2-332","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"2","key":"10087_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/MNH.0b013e3282f56854","volume":"17","author":"MJ Young","year":"2008","unstructured":"Young, M. J. (2008). Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation. Current Opinion in Nephrology and Hypertension, 17(2), 174\u2013180. https:\/\/doi.org\/10.1097\/MNH.0b013e3282f56854","journal-title":"Current Opinion in Nephrology and Hypertension"},{"issue":"2","key":"10087_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00395-024-01032-6","volume":"119","author":"D Fraccarollo","year":"2024","unstructured":"Fraccarollo, D., Geffers, R., Galuppo, P., & Bauersachs, J. (2024). Mineralocorticoid receptor promotes cardiac macrophage inflammaging. Basic Research in Cardiology, 119(2), 243\u2013260. https:\/\/doi.org\/10.1007\/s00395-024-01032-6","journal-title":"Basic Research in Cardiology"},{"issue":"6","key":"10087_CR17","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jelectrocard.2012.08.005","volume":"45","author":"KS McDowell","year":"2012","unstructured":"McDowell, K. S., Vadakkumpadan, F., Blake, R., et al. (2012). Methodology for patient-specific modeling of atrial fibrosis as a substrate for atrial fibrillation. Journal of Electrocardiology, 45(6), 640\u2013645. https:\/\/doi.org\/10.1016\/j.jelectrocard.2012.08.005","journal-title":"Journal of Electrocardiology"},{"issue":"9","key":"10087_CR18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","volume":"114","author":"J Andrade","year":"2014","unstructured":"Andrade, J., Khairy, P., Dobrev, D., & Nattel, S. (2014). The clinical profile and pathophysiology of atrial fibrillation. Circulation Research, 114(9), 1453\u20131468. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.303211","journal-title":"Circulation Research"},{"issue":"4","key":"10087_CR19","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/cvr\/cvq329","volume":"89","author":"L Yue","year":"2011","unstructured":"Yue, L., Xie, J., & Nattel, S. (2011). Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovascular Research, 89(4), 744\u2013753. https:\/\/doi.org\/10.1093\/cvr\/cvq329","journal-title":"Cardiovascular Research"},{"issue":"2","key":"10087_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1536\/ihj.21-677","volume":"63","author":"Y Iwasaki","year":"2022","unstructured":"Iwasaki, Y., Sekiguchi, A., Kato, T., & Yamashita, T. (2022). Glucocorticoid induces atrial arrhythmogenesis via modification of ion channel gene expression in rats. International Heart Journal, 63(2), 21\u2013677. https:\/\/doi.org\/10.1536\/ihj.21-677","journal-title":"International Heart Journal"},{"issue":"16","key":"10087_CR21","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1161\/CIRCULATIONAHA.108.805804","volume":"119","author":"AM G\u00f3mez","year":"2009","unstructured":"G\u00f3mez, A. M., Rueda, A., Sainte-Marie, Y., et al. (2009). Mineralocorticoid modulation of cardiac ryanodine receptor activity is associated with downregulation of FK506-Binding Proteins. Circulation, 119(16), 2179\u20132187. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.805804","journal-title":"Circulation"},{"issue":"16","key":"10087_CR22","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1093\/hmg\/ddt182","volume":"22","author":"EA Rog-Zielinska","year":"2013","unstructured":"Rog-Zielinska, E. A., Thomson, A., Kenyon, C. J., et al. (2013). Glucocorticoid receptor is required for foetal heart maturation. Human Molecular Genetics, 22(16), 3269\u20133282. https:\/\/doi.org\/10.1093\/hmg\/ddt182","journal-title":"Human Molecular Genetics"},{"issue":"2","key":"10087_CR23","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1210\/en.2010-0829","volume":"152","author":"YY Fan","year":"2011","unstructured":"Fan, Y. Y., Kohno, M., Hitomi, H., et al. (2011). Aldosterone\/Mineralocorticoid Receptor Stimulation induces cellular senescence in the kidney. Endocrinology, 152(2), 680\u2013688. https:\/\/doi.org\/10.1210\/en.2010-0829","journal-title":"Endocrinology"},{"issue":"1","key":"10087_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9010036","volume":"9","author":"L Jesel","year":"2019","unstructured":"Jesel, L., Abbas, M., Park, S. H., et al. (2019). Atrial fibrillation progression is associated with cell senescence burden as determined by p53 and p16 expression. Journal of Clinical Medicine, 9(1), Article 36. https:\/\/doi.org\/10.3390\/jcm9010036","journal-title":"Journal of Clinical Medicine"},{"issue":"35","key":"10087_CR25","doi-asserted-by":"publisher","first-page":"57981","DOI":"10.18632\/oncotarget.19853","volume":"8","author":"J Xie","year":"2017","unstructured":"Xie, J., Chen, Y., Hu, C., et al. (2017). Premature senescence of cardiac fibroblasts and atrial fibrosis in patients with atrial fibrillation. Oncotarget, 8(35), 57981\u201357990. https:\/\/doi.org\/10.18632\/oncotarget.19853","journal-title":"Oncotarget"},{"key":"10087_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.067918","author":"JA Leopold","year":"2011","unstructured":"Leopold, J. A. (2011). Aldosterone, mineralocorticoid receptor activation, and cardiovascular remodeling. Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.067918","journal-title":"Circulation"},{"issue":"1","key":"10087_CR27","doi-asserted-by":"publisher","first-page":"H458","DOI":"10.1152\/ajpheart.00824.2003","volume":"286","author":"DA Scheuer","year":"2004","unstructured":"Scheuer, D. A., Bechtold, A. G., Shank, S. S., & Akana, S. F. (2004). Glucocorticoids act in the dorsal hindbrain to increase arterial pressure. American Journal of Physiology-Heart and Circulatory Physiology, 286(1), H458\u2013H467. https:\/\/doi.org\/10.1152\/ajpheart.00824.2003","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"8","key":"10087_CR28","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00424-022-02715-6","volume":"474","author":"S Verouti","year":"2022","unstructured":"Verouti, S., Hummler, E., & Vanderriele, P. E. (2022). Role of glucocorticoid receptor mutations in hypertension and adrenal gland hyperplasia. Pfl\u00fcgers Archiv\u202f: European Journal of Physiology, 474(8), 829\u2013840. https:\/\/doi.org\/10.1007\/s00424-022-02715-6","journal-title":"Pfl\u00fcgers Archiv : European Journal of Physiology"},{"issue":"2","key":"10087_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10654-022-00914-0","volume":"38","author":"D Aune","year":"2023","unstructured":"Aune, D., Mahamat-Saleh, Y., Kobeissi, E., Feng, T., Heath, A. K., & Janszky, I. (2023). Blood pressure, hypertension and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies. European Journal of Epidemiology, 38(2), 145\u2013178. https:\/\/doi.org\/10.1007\/s10654-022-00914-0","journal-title":"European Journal of Epidemiology"},{"issue":"11","key":"10087_CR30","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1210\/en.2012-1563","volume":"153","author":"R Ren","year":"2012","unstructured":"Ren, R., Oakley, R. H., Cruz-Topete, D., & Cidlowski, J. A. (2012). Dual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosis. Endocrinology, 153(11), 5346\u20135360. https:\/\/doi.org\/10.1210\/en.2012-1563","journal-title":"Endocrinology"},{"issue":"1","key":"10087_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0008-6363(02)00338-3","volume":"55","author":"C R\u00fccker-Martin","year":"2002","unstructured":"R\u00fccker-Martin, C. (2002). Dedifferentiation of atrial myocytes during atrial fibrillation: Role of fibroblast proliferation in vitro. Cardiovascular Research, 55(1), 38\u201352. https:\/\/doi.org\/10.1016\/S0008-6363(02)00338-3","journal-title":"Cardiovascular Research"},{"issue":"4","key":"10087_CR32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","volume":"12","author":"YF Hu","year":"2015","unstructured":"Hu, Y. F., Chen, Y. J., Lin, Y. J., & Chen, S. A. (2015). Inflammation and the pathogenesis of atrial fibrillation. Nature Reviews. Cardiology, 12(4), 230\u2013243. https:\/\/doi.org\/10.1038\/nrcardio.2015.2","journal-title":"Nature Reviews. Cardiology"},{"key":"10087_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.872446","author":"Z Xue","year":"2022","unstructured":"Xue, Z., Guo, S., Liu, X., et al. (2022). Impact of COPD or asthma on the risk of atrial fibrillation: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. https:\/\/doi.org\/10.3389\/fcvm.2022.872446","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"9","key":"10087_CR34","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.9.1016","volume":"166","author":"CS van der Hooft","year":"2006","unstructured":"van der Hooft, C. S., Heeringa, J., Brusselle, G. G., et al. (2006). Corticosteroids and the risk of atrial fibrillation. Archives of Internal Medicine, 166(9), Article 1016. https:\/\/doi.org\/10.1001\/archinte.166.9.1016","journal-title":"Archives of Internal Medicine"},{"issue":"12","key":"10087_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003432","volume":"17","author":"M Pujades-Rodriguez","year":"2020","unstructured":"Pujades-Rodriguez, M., Morgan, A. W., Cubbon, R. M., & Wu, J. (2020). Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study. PLoS Medicine, 17(12), Article e1003432. https:\/\/doi.org\/10.1371\/journal.pmed.1003432","journal-title":"PLoS Medicine"},{"key":"10087_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.305","author":"R De Caterina","year":"2010","unstructured":"De Caterina, R., Ruig\u00f3mez, A., & Rodr\u00edguez, L. A. G. (2010). Long-term use of anti-inflammatory drugs and risk of atrial fibrillation. Archives of Internal Medicine. https:\/\/doi.org\/10.1001\/archinternmed.2010.305","journal-title":"Archives of Internal Medicine"},{"issue":"9","key":"10087_CR37","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1053\/j.jvca.2022.05.011","volume":"36","author":"RSJ Tan","year":"2022","unstructured":"Tan, R. S. J., Ng, K. T., Xin, C. E., Atan, R., Yunos, N. M., & Hasan, M. S. (2022). High-dose versus low-dose corticosteroids in COVID-19 patients: A systematic review and meta-analysis. Journal of Cardiothoracic and Vascular Anesthesia, 36(9), 3576\u20133586. https:\/\/doi.org\/10.1053\/j.jvca.2022.05.011","journal-title":"Journal of Cardiothoracic and Vascular Anesthesia"},{"issue":"4","key":"10087_CR38","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1513\/AnnalsATS.202208-720OC","volume":"20","author":"T Pitre","year":"2023","unstructured":"Pitre, T., Su, J., Mah, J., et al. (2023). Higher- versus lower-dose corticosteroids for severe to critical COVID-19: A systematic review and dose\u2013response meta-analysis. Annals of the American Thoracic Society, 20(4), 596\u2013604. https:\/\/doi.org\/10.1513\/AnnalsATS.202208-720OC","journal-title":"Annals of the American Thoracic Society"},{"issue":"3","key":"10087_CR39","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/01.ede.0000158743.90664.a7","volume":"16","author":"C Huerta","year":"2005","unstructured":"Huerta, C., Lanes, S. F., & Garc\u00eda Rodr\u00edguez, L. A. (2005). Respiratory medications and the risk of cardiac arrhythmias. Epidemiology, 16(3), 360\u2013366. https:\/\/doi.org\/10.1097\/01.ede.0000158743.90664.a7","journal-title":"Epidemiology"},{"issue":"23","key":"10087_CR40","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1136\/heartjnl-2019-315560","volume":"105","author":"R Bing","year":"2019","unstructured":"Bing, R., & Dweck, M. R. (2019). Myocardial fibrosis: Why image, how to image and clinical implications. Heart, 105(23), 1832\u20131840. https:\/\/doi.org\/10.1136\/heartjnl-2019-315560","journal-title":"Heart"},{"issue":"2","key":"10087_CR41","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3803\/EnM.2017.32.2.180","volume":"32","author":"S Suh","year":"2017","unstructured":"Suh, S., & Park, M. K. (2017). Glucocorticoid-induced diabetes mellitus: An important but overlooked problem. Endocrinology and Metabolism, 32(2), 180. https:\/\/doi.org\/10.3803\/EnM.2017.32.2.180","journal-title":"Endocrinology and Metabolism"},{"issue":"5","key":"10087_CR42","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jdiacomp.2018.02.004","volume":"32","author":"D Aune","year":"2018","unstructured":"Aune, D., Feng, T., Schlesinger, S., Janszky, I., Norat, T., & Riboli, E. (2018). Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies. Journal of Diabetes and Its Complications, 32(5), 501\u2013511. https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.02.004","journal-title":"Journal of Diabetes and Its Complications"},{"issue":"10","key":"10087_CR43","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.amjcard.2014.08.015","volume":"114","author":"G Liu","year":"2014","unstructured":"Liu, G., Yan, Y. P., Zheng, X. X., et al. (2014). Meta-analysis of nonsteroidal anti-inflammatory drug use and risk of atrial fibrillation. American Journal of Cardiology, 114(10), 1523\u20131529. https:\/\/doi.org\/10.1016\/j.amjcard.2014.08.015","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"10087_CR44","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/rheumatology\/kead510","volume":"63","author":"LSF de Carvalho","year":"2024","unstructured":"de Carvalho, L. S. F., Koeche, C., & Pugliesi, A. (2024). DMARD-specific risk of atrial fibrillation in rheumatoid arthritis: A new piece in the puzzle. Rheumatology (Oxford, England), 63(3), 591\u2013593. https:\/\/doi.org\/10.1093\/rheumatology\/kead510","journal-title":"Rheumatology (Oxford, England)"},{"key":"10087_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00347","author":"D Cruz-Topete","year":"2020","unstructured":"Cruz-Topete, D., Oakley, R. H., & Cidlowski, J. A. (2020). Glucocorticoid signaling and the aging heart. Frontiers in Endocrinology (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2020.00347","journal-title":"Frontiers in Endocrinology (Lausanne)"},{"issue":"3","key":"10087_CR46","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3892\/etm.2013.899","volume":"5","author":"GJ Xu","year":"2013","unstructured":"Xu, G. J., Gan, T. Y., Tang, B. P., et al. (2013). Accelerated fibrosis and apoptosis with ageing and in atrial fibrillation: Adaptive responses with maladaptive consequences. Experimental and Therapeutic Medicine, 5(3), 723\u2013729. https:\/\/doi.org\/10.3892\/etm.2013.899","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10087_CR47","doi-asserted-by":"publisher","first-page":"A1588","DOI":"10.1097\/01.ccm.0000458443.11317.7a","volume":"42","author":"S Kane","year":"2014","unstructured":"Kane, S., & Hanes, S. (2014). Impact of hydrocortisone on atrial fibrillation in septic shock. Critical Care Medicine, 42, A1588. https:\/\/doi.org\/10.1097\/01.ccm.0000458443.11317.7a","journal-title":"Critical Care Medicine"},{"issue":"3","key":"10087_CR48","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/0885066617696847","volume":"34","author":"Y Launey","year":"2019","unstructured":"Launey, Y., Lasocki, S., Asehnoune, K., et al. (2019). Impact of low-dose hydrocortisone on the incidence of atrial fibrillation in patients with septic shock: A propensity score-inverse probability of treatment weighting cohort study. Journal of Intensive Care Medicine, 34(3), 238\u2013244. https:\/\/doi.org\/10.1177\/0885066617696847","journal-title":"Journal of Intensive Care Medicine"},{"issue":"1","key":"10087_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1511-2","volume":"20","author":"S Tongyoo","year":"2016","unstructured":"Tongyoo, S., Permpikul, C., Mongkolpun, W., et al. (2016). Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: Results of a randomized controlled trial. Critical Care, 20(1), Article 329. https:\/\/doi.org\/10.1186\/s13054-016-1511-2","journal-title":"Critical Care"},{"issue":"1","key":"10087_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0740-0","volume":"19","author":"F Venet","year":"2015","unstructured":"Venet, F., Plassais, J., Textoris, J., et al. (2015). Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: A randomized clinical trial. Critical Care, 19(1), Article 21. https:\/\/doi.org\/10.1186\/s13054-015-0740-0","journal-title":"Critical Care"},{"issue":"1","key":"10087_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-022-01021-9","volume":"12","author":"MA Ammar","year":"2022","unstructured":"Ammar, M. A., Ammar, A. A., Wieruszewski, P. M., et al. (2022). Timing of vasoactive agents and corticosteroid initiation in septic shock. Annals of Intensive Care, 12(1), Article 47. https:\/\/doi.org\/10.1186\/s13613-022-01021-9","journal-title":"Annals of Intensive Care"},{"issue":"3","key":"10087_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00210-009-0474-0","volume":"381","author":"AJ Workman","year":"2010","unstructured":"Workman, A. J. (2010). Cardiac adrenergic control and atrial fibrillation. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology, 381(3), 235\u2013249. https:\/\/doi.org\/10.1007\/s00210-009-0474-0","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"11","key":"10087_CR53","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans, L., Rhodes, A., Alhazzani, W., et al. (2021). Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Medicine, 47(11), 1181\u20131247. https:\/\/doi.org\/10.1007\/s00134-021-06506-y","journal-title":"Intensive Care Medicine"},{"issue":"2","key":"10087_CR54","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/joa3.12995","volume":"40","author":"V Jaiswal","year":"2024","unstructured":"Jaiswal, V., Roy, P., Ang, S. P., et al. (2024). Association between rheumatoid arthritis and atrial fibrillation: A systematic review and meta-analysis. Journal of Arrhythmia, 40(2), 203\u2013213. https:\/\/doi.org\/10.1002\/joa3.12995","journal-title":"Journal of Arrhythmia"},{"issue":"8","key":"10087_CR55","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1177\/1060028019900500","volume":"54","author":"M Bylo","year":"2020","unstructured":"Bylo, M., Farewell, R., Coppenrath, V. A., & Yogaratnam, D. (2020). A review of Deflazacort for patients with Duchenne muscular dystrophy. Annals of Pharmacotherapy, 54(8), 788\u2013794. https:\/\/doi.org\/10.1177\/1060028019900500","journal-title":"Annals of Pharmacotherapy"},{"issue":"7","key":"10087_CR56","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10654-020-00613-8","volume":"35","author":"E Landfeldt","year":"2020","unstructured":"Landfeldt, E., Thompson, R., Sejersen, T., McMillan, H. J., Kirschner, J., & Lochm\u00fcller, H. (2020). Life expectancy at birth in Duchenne muscular dystrophy: A systematic review and meta-analysis. European Journal of Epidemiology, 35(7), 643\u2013653. https:\/\/doi.org\/10.1007\/s10654-020-00613-8","journal-title":"European Journal of Epidemiology"},{"issue":"2","key":"10087_CR57","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2165\/00003495-199550020-00008","volume":"50","author":"A Markham","year":"1995","unstructured":"Markham, A., & Bryson, H. M. (1995). Deflazacort. A review of its pharmacological properties and therapeutic efficacy. Drugs, 50(2), 317\u2013333. https:\/\/doi.org\/10.2165\/00003495-199550020-00008","journal-title":"Drugs"},{"issue":"3","key":"10087_CR58","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/bcp.12637","volume":"80","author":"PT Daley-Yates","year":"2015","unstructured":"Daley-Yates, P. T. (2015). Inhaled corticosteroids: Potency, dose equivalence and therapeutic index. British Journal of Clinical Pharmacology, 80(3), 372\u2013380. https:\/\/doi.org\/10.1111\/bcp.12637","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10087_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2019.101828","volume":"58","author":"MG Matera","year":"2019","unstructured":"Matera, M. G., Rinaldi, B., Calzetta, L., Rogliani, P., & Cazzola, M. (2019). Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatment. Pulmonary Pharmacology & Therapeutics, 58, Article 101828. https:\/\/doi.org\/10.1016\/j.pupt.2019.101828","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"issue":"9","key":"10087_CR60","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1016\/j.xphs.2016.05.004","volume":"105","author":"JK Mukker","year":"2016","unstructured":"Mukker, J. K., Singh, R. S. P., & Derendorf, H. (2016). Ciclesonide: A pro-soft drug approach for mitigation of side effects of inhaled corticosteroids. Journal of Pharmaceutical Sciences, 105(9), 2509\u20132514. https:\/\/doi.org\/10.1016\/j.xphs.2016.05.004","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10087_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2025.107962","volume":"238","author":"TG Ottesen","year":"2025","unstructured":"Ottesen, T. G., Rovsing, A. H., & Ulrik, C. S. (2025). Local and systemic adverse effects of inhaled corticosteroids - Does ciclesonide differ from other inhaled corticosteroids? Respiratory Medicine, 238, Article 107962. https:\/\/doi.org\/10.1016\/j.rmed.2025.107962","journal-title":"Respiratory Medicine"},{"issue":"4","key":"10087_CR62","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4103\/2229-3485.167092","volume":"6","author":"P Ranganathan","year":"2015","unstructured":"Ranganathan, P., Aggarwal, R., & Pramesh, C. (2015). Common pitfalls in statistical analysis: Odds versus risk. Perspectives in Clinical Research, 6(4), 222. https:\/\/doi.org\/10.4103\/2229-3485.167092","journal-title":"Perspectives in Clinical Research"},{"issue":"4","key":"10087_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58040530","volume":"58","author":"G Bagnato","year":"2022","unstructured":"Bagnato, G., Imbalzano, E., Aragona, C. O., et al. (2022). New-onset atrial fibrillation and early mortality rate in COVID-19 patients: Association with IL-6 serum levels and respiratory distress. Medicina (Buenos Aires), 58(4), Article 530. https:\/\/doi.org\/10.3390\/medicina58040530","journal-title":"Medicina (Buenos Aires)"},{"issue":"2","key":"10087_CR64","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ijcard.2014.07.087","volume":"176","author":"WL Chan","year":"2014","unstructured":"Chan, W. L., Yang, K. P., Chao, T. F., et al. (2014). The association of asthma and atrial fibrillation \u2014 A nationwide population-based nested case\u2013control study. International Journal of Cardiology, 176(2), 464\u2013469. https:\/\/doi.org\/10.1016\/j.ijcard.2014.07.087","journal-title":"International Journal of Cardiology"},{"issue":"18","key":"10087_CR65","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1001\/archinternmed.2009.297","volume":"169","author":"CF Christiansen","year":"2009","unstructured":"Christiansen, C. F. (2009). Glucocorticoid use and risk of atrial fibrillation or flutter. Archives of Internal Medicine, 169(18), 1677. https:\/\/doi.org\/10.1001\/archinternmed.2009.297","journal-title":"Archives of Internal Medicine"},{"issue":"5","key":"10087_CR66","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/joa3.12619","volume":"37","author":"B Erg\u00fcn","year":"2021","unstructured":"Erg\u00fcn, B., Ergan, B., S\u00f6zmen, M. K., et al. (2021). New-onset atrial fibrillation in critically ill patients with coronavirus disease 2019 (COVID\u201019). Journal of Arrhythmia, 37(5), 1196\u20131204. https:\/\/doi.org\/10.1002\/joa3.12619","journal-title":"Journal of Arrhythmia"},{"issue":"587","key":"10087_CR67","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.3399\/bjgp11X578034","volume":"61","author":"JA Hodgkinson","year":"2011","unstructured":"Hodgkinson, J. A., Taylor, C. J., & Hobbs, F. R. (2011). Predictors of incident atrial fibrillation and influence of medications: A retrospective case\u2013control study. British Journal of General Practice, 61(587), e353\u2013e361. https:\/\/doi.org\/10.3399\/bjgp11X578034","journal-title":"British Journal of General Practice"},{"issue":"3","key":"10087_CR68","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000121600","volume":"111","author":"IA Kindem","year":"2008","unstructured":"Kindem, I. A., Reindal, E. K., Wester, A. L., Blaasaas, K. G., & Atar, D. (2008). New-onset atrial fibrillation in bacteremia is not associated with C-reactive protein, but is an indicator of increased mortality during hospitalization. Cardiology, 111(3), 171\u2013180. https:\/\/doi.org\/10.1159\/000121600","journal-title":"Cardiology"},{"issue":"1","key":"10087_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-51177-6","volume":"14","author":"D Ko","year":"2024","unstructured":"Ko, D., Treu, T. M., Tarko, L., et al. (2024). Incidence and prognostic significance of newly-diagnosed atrial fibrillation among older U.S. veterans hospitalized with COVID-19. Scientific Reports, 14(1), Article 952. https:\/\/doi.org\/10.1038\/s41598-024-51177-6","journal-title":"Scientific Reports"},{"issue":"9","key":"10087_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(22)01187-1","volume":"79","author":"D McMahan","year":"2022","unstructured":"McMahan, D., Patel, A., Jipescu, D., & Thambidorai, S. (2022). The incidence of new-onset atrial fibrillation in hospitalized COVID-19 patients receiving high dose corticosteroids. Journal of the American College of Cardiology, 79(9), Article 196. https:\/\/doi.org\/10.1016\/S0735-1097(22)01187-1","journal-title":"Journal of the American College of Cardiology"},{"issue":"9","key":"10087_CR71","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.jacep.2021.02.009","volume":"7","author":"DR Musikantow","year":"2021","unstructured":"Musikantow, D. R., Turagam, M. K., Sartori, S., et al. (2021). Atrial fibrillation in patients hospitalized with COVID-19. JACC. Clinical Electrophysiology, 7(9), 1120\u20131130. https:\/\/doi.org\/10.1016\/j.jacep.2021.02.009","journal-title":"JACC. Clinical Electrophysiology"},{"issue":"12","key":"10087_CR72","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1111\/jce.14770","volume":"31","author":"B Peltzer","year":"2020","unstructured":"Peltzer, B., Manocha, K. K., Ying, X., et al. (2020). Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19. Journal of Cardiovascular Electrophysiology, 31(12), 3077\u20133085. https:\/\/doi.org\/10.1111\/jce.14770","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10087_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.813","author":"FS Rahimi","year":"2022","unstructured":"Rahimi, F. S., Afaghi, S., Tarki, F. E., Omran, H. S., & Nasirpour, M. H. (2022). Risk factors, thromboembolic events, and clinical course of New-Onset Atrial Fibrillation among COVID\u201019 hospitalized patients: A multicenter cross\u2010sectional analysis in Iran. Health Sci Rep. https:\/\/doi.org\/10.1002\/hsr2.813","journal-title":"Health Sci Rep"},{"key":"10087_CR74","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.121.010666","author":"AG Rosenblatt","year":"2022","unstructured":"Rosenblatt, A. G., Ayers, C. R., Rao, A., et al. (2022). New-Onset Atrial Fibrillation in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Registry. Circ Arrhythm Electrophysiol. https:\/\/doi.org\/10.1161\/CIRCEP.121.010666","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"10087_CR75","doi-asserted-by":"publisher","first-page":"148","DOI":"10.14740\/jocmr4884","volume":"15","author":"J Shin","year":"2023","unstructured":"Shin, J., Andrews, M., DeJean, L., et al. (2023). Risk Factors Associated With Atrial Fibrillation in Elderly Patients. Journal of Clinical Medicine Research, 15(3), 148\u2013160. https:\/\/doi.org\/10.14740\/jocmr4884","journal-title":"Journal of Clinical Medicine Research"},{"issue":"2","key":"10087_CR76","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10840-021-01029-4","volume":"64","author":"L Slipczuk","year":"2022","unstructured":"Slipczuk, L., Castagna, F., Schonberger, A., et al. (2022). Incidence of new-onset atrial fibrillation in COVID-19 is associated with increased epicardial adipose tissue. Journal of Interventional Cardiac Electrophysiology, 64(2), 383\u2013391. https:\/\/doi.org\/10.1007\/s10840-021-01029-4","journal-title":"Journal of Interventional Cardiac Electrophysiology"},{"issue":"2","key":"10087_CR77","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1177\/08850666211053548","volume":"37","author":"K Al Sulaiman","year":"2022","unstructured":"Al Sulaiman, K., Aljuhani, O., Al Aamer, K., et al. (2022). The role of inhaled corticosteroids (ICS) in critically ill patients with COVID-19: A multicenter, cohort study. Journal of Intensive Care Medicine, 37(2), 248\u2013257. https:\/\/doi.org\/10.1177\/08850666211053548","journal-title":"Journal of Intensive Care Medicine"},{"issue":"4","key":"10087_CR78","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cmi.2020.11.035","volume":"27","author":"VT Tran","year":"2021","unstructured":"Tran, V. T., Mah\u00e9vas, M., Bani-Sadr, F., et al. (2021). Corticosteroids in patients hospitalized for COVID-19 pneumonia who require oxygen: Observational comparative study using routine care data. Clinical Microbiology and Infection, 27(4), 603\u2013610. https:\/\/doi.org\/10.1016\/j.cmi.2020.11.035","journal-title":"Clinical Microbiology and Infection"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-025-10087-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-025-10087-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-025-10087-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:35:04Z","timestamp":1769222104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-025-10087-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10087"],"URL":"https:\/\/doi.org\/10.1007\/s12012-025-10087-3","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"10 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no affiliations with any organization or institution that holds financial or non-financial interests in the subject matter or materials discussed in this publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"14"}}